Insperity (NSP) Rebound Keeps Focus On Its Earnings Recovery Story As Undervalued View Builds
Insperity (NSP) has drawn fresh attention after its shares moved sharply over the past month, with the stock up around 30% and roughly 46% over the past 3 months.
See our latest analysis for Insperity.
At a latest share price of $47.98, Insperity’s recent 30 day share price return of about 30% and 90 day gain of roughly 46% contrast with a 1 year total shareholder return that is down about 13%, suggesting short term momentum against a weaker longer term picture.
If Insperity’s move has you reassessing where opportunity might be building next, this is a good moment to broaden your watchlist and check out 17 top founder-led companies
Bulls point to Insperity’s strong recent rebound and annual net income growth, while bears flag the recent loss and weak multi year returns. How does the current valuation weigh those two stories?
Most Popular Narrative: 11.1% Undervalued
Compared with Insperity’s last close at $47.98, the most followed narrative sees fair value at $54.00, framing today’s price as a discount worth understanding.
The bullish analysts expect earnings to reach $121.8 million (and earnings per share of $3.18) by about June 2029, up from -$25.0 million today. The analysts are largely in agreement about this estimate.
Want to see what sits behind that shift from losses to meaningful earnings? The narrative leans on steady revenue expansion, firmer margins, and a richer earnings multiple, all carefully tied together in one valuation story.
Result: Fair Value of $54 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Insperity’s story still carries real risk, with healthcare cost pressures and slower worksite employee growth both capable of undermining that upbeat earnings narrative.
Find out about the key risks to this Insperity narrative.
Next Steps
If the mix of optimism and concern around Insperity feels finely balanced, it is worth acting quickly to check the underlying data for yourself and weigh the 3 key rewards and 1 important warning sign
Looking for more ideas beyond Insperity?
If Insperity has sharpened your focus on where capital could work harder, do not stop here. Broaden your opportunity set with a few targeted stock ideas.
- Target potential upside in overlooked value by checking out 38 high quality undervalued stocks before prices fully reflect their fundamentals.
- Strengthen your income stream by reviewing 7 dividend fortresses that offer higher yields with an emphasis on durability.
- Dial down portfolio risk by considering 79 resilient stocks with low risk scores designed to prioritise resilience when conditions change.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com